MARC details
| 000 -LEADER |
|---|
| fixed length control field |
05105nam a22003733i 4500 |
| 001 - CONTROL NUMBER |
|---|
| control field |
EBC5163861 |
| 003 - CONTROL NUMBER IDENTIFIER |
|---|
| control field |
MiAaPQ |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20230831122158.0 |
| 006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS |
|---|
| fixed length control field |
m o d | |
| 007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION |
|---|
| fixed length control field |
cr cnu|||||||| |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
220816s2005 xx o ||||0 eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9780853695820 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9780857111173 (e-book) |
| 040 ## - CATALOGING SOURCE |
|---|
| Original cataloging agency |
MiAaPQ |
| Language of cataloging |
eng |
| Description conventions |
rda |
| -- |
pn |
| Transcribing agency |
MiAaPQ |
| Modifying agency |
IE-CoMTU |
| 082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER |
|---|
| Classification number |
362.29 |
| 100 1# - MAIN ENTRY--PERSONAL NAME |
|---|
| Personal name |
Wills, Simon |
| Relator term |
author |
| 9 (RLIN) |
133493 |
| 245 10 - TITLE STATEMENT |
|---|
| Title |
Drugs of abuse |
| Medium |
[electronic book] / |
| Statement of responsibility, etc. |
Simon Wills. |
| 250 ## - EDITION STATEMENT |
|---|
| Edition statement |
Second edition. |
| 264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE |
|---|
| Place of production, publication, distribution, manufacture |
London : |
| Name of producer, publisher, distributor, manufacturer |
Pharmaceutical Press, |
| Date of production, publication, distribution, manufacture, or copyright notice |
2005. |
| 264 #4 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE |
|---|
| Date of production, publication, distribution, manufacture, or copyright notice |
©2005 |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
1 online resource (416 pages) |
| 336 ## - CONTENT TYPE |
|---|
| Content type term |
text |
| Source |
rdacontent |
| 337 ## - MEDIA TYPE |
|---|
| Media type term |
computer |
| Source |
rdamedia |
| 338 ## - CARRIER TYPE |
|---|
| Carrier type term |
online resource |
| Source |
rdacarrier |
| 505 0# - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
The global problem -- Concepts -- Withdrawing drugs in dependence -- Methods of administration -- Drug abuse environments -- Legalisation -- Injection of drugs -- Infection -- Irritant effects -- Emboli, blood vessel occlusion and thrombosis -- Pharmacological effects -- 'Stigmata' -- Opioids -- History -- Effects sought -- Administration -- Pharmacokinetics and pharmacology -- Adverse effects -- Opioid dependence -- Interactions with medicines -- Use and concurrent illness -- Pregnancy and breastfeeding -- Cannabis -- History -- Effects sought -- Administration -- Pharmacokinetics and pharmacology -- Adverse effects -- Dependence -- Interactions with medicines -- Abuse and concurrent illness -- Pregnancy and breastfeeding -- Cocaine -- History -- Effects sought -- Administration -- Pharmacokinetics and pharmacology -- Adverse effects -- Dependence -- Interactions with medicines -- Use and concurrent illness -- Pregnancy and breastfeeding -- Amfetamine, metamfetamine, ecstasy and related drugs -- History -- Effects sought -- Administration -- Pharmacokinetics and pharmacology -- Adverse effects -- Dependence -- Other amfetamine derivatives -- Interactions with medicines -- Use and concurrent illness -- Pregnancy and breastfeeding -- LSD -- History -- Effects sought -- Administration -- Pharmacokinetics and pharmacology -- Adverse effects -- Dependence -- Interactions with medicines -- Abuse and concurrent illness -- Pregnancy and breastfeeding -- Gamma hydroxybutyrate -- History -- Effects sought -- Administration -- Pharmacokinetics and pharmacology. |
| 505 0# - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
Adverse effects -- Interactions with medicines -- Use and concurrent illness -- Pregnancy and breastfeeding -- Phencyclidine -- History -- Effects sought -- Administration -- Pharmacokinetics and pharmacology -- Adverse effects -- Volatile substance abuse -- History -- Effects sought -- Administration -- Pharmacokinetics -- Adverse effects -- Long-term use -- Pregnancy and breastfeeding -- Reducing the abuse problem -- Performance-enhancing drugs -- Anabolic-androgenic steroids -- Androgenic-anabolic steroid precursors -- Analgesics -- Beta-blockers -- Clenbuterol -- Diltiazem -- Diuretics -- Erythropoietin -- Nutritional supplements -- Prescription drugs -- Anaesthetics -- Antidepressants -- Antimuscarinic drugs -- Sedatives -- Other drugs -- Over-the-counter products -- Extent of the problem -- Sympathomimetics -- Dextromethorphan -- Opioid-containing preparations -- Analgesics -- Antihistamines -- Laxatives -- Miscellaneous OTC preparations -- Illicit drug manufacture -- Controlling the problem -- Caffeine -- History -- Effects sought -- Administration -- Pharmacokinetics and pharmacology -- Adverse effects -- Caffeine dependence and withdrawal -- Interaction with medicines -- Pregnancy and breastfeeding -- Tobacco -- History -- Effects sought -- Administration -- Pharmacokinetics and pharmacology -- Adverse effects -- Interaction with medicines -- Pregnancy and breastfeeding -- Alcohol -- History -- Effects sought -- Administration -- Pharmacokinetics and pharmacology -- Adverse effects -- Alcohol withdrawal -- Maintaining abstinence -- Interactions with medicines -- Pregnancy and breastfeeding -- |
| 505 0# - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
Plants and fungi -- Ayahuasca -- Betel -- Caffeine-containing plants -- Ephedra -- Ginseng -- Kava -- Khat -- Morning glory -- Mushrooms -- Nutmeg -- Peyote cactus -- Potato family -- Salvia divinorum -- Yohimbe -- Alkyl -- Claims made for smart drugs -- Modes of action -- Future use of smart drugs -- Substance misuse and the Internet -- User-oriented sites of street terminology -- Legal status of drugs in the UK -- Misuse of Drugs Act (1971) -- Misuse of Drugs Regulations (updated 2001) -- Drugs not covered. |
| 520 ## - SUMMARY, ETC. |
|---|
| Summary, etc. |
A concise, easy to read guide for healthcare professionals who encounter drug abuse. Each chapter deals with a different drug or gourp of drugs and has been extensively revised to reflect new research on adverse effects, treatments and patterns of use. |
| 533 ## - REPRODUCTION NOTE |
|---|
| Type of reproduction |
Electronic reproduction.: |
| Agency responsible for reproduction |
ProQuest LibCentral. |
| Note about reproduction |
Mode of access: World Wide Web. |
| 590 ## - LOCAL NOTE (RLIN) |
|---|
| Local Note |
Self-Care Collection |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Drugs of abuse |
| 9 (RLIN) |
45566 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS |
|---|
| Uniform Resource Identifier |
<a href="https://ebookcentral.proquest.com/lib/munster/detail.action?docID=5163861">https://ebookcentral.proquest.com/lib/munster/detail.action?docID=5163861</a> |
| Public note |
E-book |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Koha item type |
e-BOOK |
| Source of classification or shelving scheme |
Dewey Decimal Classification |
| -- |
96140 |
| -- |
Brian O Neill |